About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 257 record(s)
Req # A-2020-001678
Adverse Drug Reaction (ADR) for HYDROXYCHLOROQUINE SULFATE. Report number: E2B_01198405.Organization: Health Canada
May 2021
Req # A-2020-001744
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_02944156.Organization: Health Canada
May 2021
Req # A-2020-001765
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03481143.Organization: Health Canada
May 2021
Req # A-2020-001766
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03481161.Organization: Health Canada
May 2021
Req # A-2020-001849
Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03531183.Organization: Health Canada
May 2021
Req # A-2020-000715
All records between December 1, 2019 to March 12, 2020, provided for the publishing of the Covid-19 webpage published on Canada.ca including the Covid-19 response related programs: https://www.canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19.html and https://www.canada.ca/en/department-finance/economic-response-plan.html.Organization: Health Canada
April 2021
Req # A-2020-001264
Work descriptions and/or organization charts for active positions within Health Canada's Chief Financial Officer Branch containing any of the following words: “audit,” “auditor,” “controller,” “controllership,” “finance,” and/or “financial.”Organization: Health Canada
April 2021
Req # A-2020-001450
Official date of Canadian Registration for drug Epival to be used in Canada. Which Provinces were registered to use Epival. Which medical facilities, hospitals, institutions were allowed to use Epival.Organization: Health Canada
April 2021
Req # A-2020-001712
Product names and number of requests for each product requested through the Special Access Program during calendar years (in order of preference): 2020, 2019, 2018.Organization: Health Canada
April 2021
Req # A-2020-001717
Copy of the following document: Gagne, L. (2016). Econometric Evaluation of Tobacco Control Initiatives in Canada, 1999-2013: Prepared for Health Canada's Tobacco Control Directorate.Organization: Health Canada
April 2021